KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $1.5 billion.

  • Boston Scientific's Shares Outstanding (Weighted Average) rose 60.48% to $1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 60.48%. This contributed to the annual value of $1.5 billion for FY2025, which is 60.48% up from last year.
  • Per Boston Scientific's latest filing, its Shares Outstanding (Weighted Average) stood at $1.5 billion for Q4 2025, which was up 60.48% from $1.5 billion recorded in Q3 2025.
  • Boston Scientific's Shares Outstanding (Weighted Average)'s 5-year high stood at $1.5 billion during Q3 2025, with a 5-year trough of $1.4 billion in Q1 2021.
  • For the 5-year period, Boston Scientific's Shares Outstanding (Weighted Average) averaged around $1.5 billion, with its median value being $1.4 billion (2023).
  • Per our database at Business Quant, Boston Scientific's Shares Outstanding (Weighted Average) tumbled by 49.62% in 2021 and then surged by 229.81% in 2023.
  • Boston Scientific's Shares Outstanding (Weighted Average) (Quarter) stood at $1.4 billion in 2021, then increased by 0.58% to $1.4 billion in 2022, then increased by 1.57% to $1.5 billion in 2023, then grew by 1.27% to $1.5 billion in 2024, then increased by 0.6% to $1.5 billion in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $1.5 billion for Q4 2025, versus $1.5 billion for Q3 2025 and $1.5 billion for Q2 2025.